Fetal aortic stenosis and changes in amniotic fluid natriuretic peptides

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 3, 2007, Pages 253.e1-253.e6

  Lubbers, Walter C ^a   Eghtesady, Pirooz ^b  

^a University of Cincinnati   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

congenital; fetal intervention; natriuretic peptide; ovine

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

AMNION FLUID; AMNION FLUID LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA STENOSIS; ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FETUS; FETUS BLOOD SAMPLING; FETUS DISEASE; FETUS SURGERY; FETUS WEIGHT; GESTATIONAL AGE; HEART LEFT VENTRICLE HYPERTROPHY; HEART WEIGHT; MATERNAL BLOOD; NONHUMAN; PRIORITY JOURNAL; SHEEP;

EID: 33847395288     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.01.003     Document Type: Article

References (23)

1. Sahn D.J., Shenker L., Reed K.L., et al. Prenatal ultrasound diagnosis of hypoplastic left heart syndrome in utero associated with hydrops fetalis. Am Heart J 104 (1982) 1368-1372
2. Bronshtein M., Zimmer E., Gerlis L.M., et al. Early ultrasound diagnosis of fetal congenital heart defects in high-risk and low-risk pregnancies. Obstet Gynecol 82 (1993) 225-229
3. Harada T., and Nagai R. The genetic disorders responsible for sudden cardiac death. Nippon Rinsho 63 (2005) 1273-1283
4. Soares G., Alvares S., Rocha C., et al. Congenital heart defects and chromosomal anomalies including 22q11 microdeletion (CATCH 22). Rev Port Cardiol 24 (2005) 349-371
5. Huhta J.C. Guidelines for the evaluation of heart failure in the fetus with or without hydrops. Pediatr Cardiol 25 (2004) 274-286
6. Huhta J.C. Right ventricular function in the human fetus. J Perinat Med 29 (2001) 381-389
7. Marshall A.C., van der Velde M.E., Tworetzky W., et al. Creation of an atrial septal defect in utero for fetuses with hypoplastic left heart syndrome and intact or highly restrictive atrial septum. Circulation 110 (2004) 253-258
8. Tworetzky W., Wilkins-Haug L., Jennings R.W., et al. Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention. Circulation 110 (2004) 2125-2131
9. Cameron V.A., and Ellmers L.J. Minireview: natriuretic peptides during development of the fetal heart and circulation. Endocrinology 144 (2003) 2191-2194
10. Cameron V.A., Aitken G.D., Ellmers L.J., Kennedy M.A., and Espiner E.A. The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology 137 (1996) 817-824
11. Cheung C.Y., Gibbs D.M., and Brace R.A. Atrial natriuretic factor in maternal and fetal sheep. Am J Physiol 252 (1987) E279-E282
12. Walther T., Schultheiss H.P., Tschope C., and Stepan H. Natriuretic peptide system in fetal heart and circulation. J Hypertens 20 (2002) 785-791
13. Itoh H., Sagawa N., Hasegawa M., et al. Brain natriuretic peptide levels in the umbilical venous plasma are elevated in fetal distress. Biol Neonate 64 (1993) 18-25
14. Walther T., Stepan H., and Faber R. Dual natriuretic peptide response to volume load in the fetal circulation. Cardiovasc Res 49 (2001) 817-819
15. Reynolds E.W., Ellington J.G., Vranicar M., and Bada H.S. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. pediatrics. Pediatrics 114 (2004) 1297-1304
16. Kunii Y., Masahiro K., Ohtsuki S., et al. Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 57 (2003) 191-197
17. Eghtesady P., Michelfelder E., Jones F., et al. Aortic stenosis in the ovine fetus: a model for fetal intervention?. Pediatr Cardiol 24 (2003) 624
18. Norman J.E., and Levy D. Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach. J Am Coll Cardiol 26 (1995) 1022-1029
19. Di Lieto A., Pollio F., Catalano D., et al. Atrial natriuretic factor in amniotic fluid and in maternal venous blood of pregnancies with fetal cardiac malformations and chromosomal abnormalities. J Matern Fetal Neonatal Med 11 (2002) 183-187
20. Itoh H., Sagawa N., Hasegawa M., et al. Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells. J Clin Endocrinol Metab 76 (1993) 907-911
21. Bergler-Klein J., Klaar U., Heger M., et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 109 (2004) 2302-2308
22. Lim P., Monin J.L., Monchi M., et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J 25 (2004) 2048-2053
23. Deloof S., VanCamp G., and Chatelain A. Absence of transplacental transfer of atrial natriuretic peptide in the rat: direct experimental evidence. Med Sci Res 23 (1995) 347-350